NCT01802502View on ClinicalTrials.gov

Rifampicin Explorative PK Study for Tuberculous Meningitis Comparing Oral and Intravenous Preparation

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

October 31, 2013

Study Completion Date

April 30, 2014

Conditions
Tuberculous Meningitis
Interventions
DRUG

Rifampicin intravenous

DRUG

Oral rifampicin

Trial Locations (1)

40122

Hasan Sadikin Hospital, Bandung

All Listed Sponsors
collaborator

Radboud University Medical Center

OTHER

lead

Universitas Padjadjaran

OTHER

NCT01802502 - Rifampicin Explorative PK Study for Tuberculous Meningitis Comparing Oral and Intravenous Preparation | Biotech Hunter | Biotech Hunter